$RLAY
Relay Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is RLAY up today? It is at $19.70 (+0.03%), and our scanner flagged it 30 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RLAY spikes, and full due diligence on RLAY — key stats, earnings, dilution and insider activity. Free.
Get free $RLAY alerts the moment volume spikes
Our scanner flagged $RLAY 30 times in the last 30 days. Create a free account to track $RLAY, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $19.70
- Change today
- +0.03%
- Previous close
- $19.69
- 52-week range
- $3.02 – $20.79
- Market cap
- $3.77B
- Total held
- 4.5%
- Tradeable float
- 182.9M 95% of shares · after 5% insiders + institutional n/a
- Short interest
- 42.6M ▼ -1% vs prior · as of 2026-07-15
- Short % of float
- 23.3%
- Days to cover
- 13.4d
- Avg daily volume
- 2.7M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 0.5x
- 15m
- 0.7x
- 1h
- 0.7x
- 1D
- 0.0x
Get free RLAY + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $RLAY moving today?
RLAY is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on RLAY today, peaking at 4.8x its normal volume.
Likely catalystCharter / Bylaw Change · Shareholder Vote, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $RLAY runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · About $87M in size · Priced at $12.00/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$RLAY Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$RLAY Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to RLAY
Comparable names in biological products, (no diagnostic substances), closest in size first.
RLAY stock FAQ
Why is $RLAY moving today?
RLAY is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on RLAY today, peaking at 4.8x its normal volume.
What is the RLAY stock price today?
RLAY last traded at $19.70, up 0.03% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live RLAY alerts?
The RLAY Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RLAY 30 times in the last 30 days.
What exchange is RLAY on?
RLAY (Relay Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $3.77B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is RLAY good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RLAY for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.